Hepatitis B News and Research

Latest Hepatitis B News and Research

Researchers examine whether new drug offers added benefit for patients with chronic HCV

The drug simeprevir has been available since May 2014 for the treatment of adult patients with chronic hepatitis C infection.

9 Sep 2014

State highlights: Texas lawmaker proposes '3 strikes' for nursing homes

New Yorker Deadra Malloy was diagnosed with HIV in 1988, but she remained healthy for so long she wasn't completely convinced she was positive.

9 Sep 2014

Canada funds 22 inventive ideas for improving health in low-resource countries

Grand Challenges Canada, funded by the Government of Canada, today announced $2.4 million in seed funds shared between 22 projects from Canada and nine developing nations, to pursue inventive new ideas for improving health in low-resource countries.

8 Sep 2014

New cancer drug renews debate about costs

The drug Opdivo, which went on sale in Japan this week, costs an average of $143,000 per patient, The Wall Street Journal reports.

5 Sep 2014

Novira completes Phase 1a clinical study of NVR-1221 for treatment of HBV infection

Novira Therapeutics, Inc., a privately held biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection, today announced successful completion of a Phase 1a clinical study of NVR-1221.

4 Sep 2014

First Edition: September 4, 2014

Today's headlines include reports about a new government report that predicts a rebound in national health spending.

4 Sep 2014

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Bristol-Myers Squibb today announced the launch of Daklinza▼ (daclatasvir) in the UK, a new medicine for the treatment of adult patients with chronic hepatitis C. Daclatasvir, a treatment that works across multiple hepatitis C genotypes, will allow up to 90% of UK patients the option of a potentially curative oral treatment regimen that does not include interferon, a standard of care commonly associated with sustained flu-like side effects.

4 Sep 2014

Two fully automated molecular testing systems for blood and plasma donor screening launched by Roche

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of the cobas 6800/8800 Systems, two integrated and fully automated molecular testing systems for blood and plasma donor screening, in markets accepting the CE mark. The cobas 6800/8800 Systems offer the fastest time to results with the highest throughput available, along with the longest walk-away time, enabling laboratory staff to drive increased workflow efficiencies, while adapting to their ever-changing testing demands.

From Roche Sequencing and Life Science 2 Sep 2014

State highlights: States seek health care autonomy; L.A. nursing home audit; promoting overdose-reversal drug

Kansas, Missouri and seven other states have signed on to a movement that would wrest regulation of most of the nation's health care insurance systems from the federal government.

30 Aug 2014

High uptake of US infant vaccination in 2013

The recently published National Immunization Survey (NIS) conducted by the CDC, shows that the majority of infants in the US were vaccinated against potentially serious diseases in 2013. Fewer than 1% of children were unvaccinated in 2013.

29 Aug 2014

International consortium to accelerate collaborative multi-site trials of potential Ebola vaccine

A candidate Ebola vaccine could be given to healthy volunteers in the UK, The Gambia and Mali as early as September, as part of an series of safety trials of potential vaccines aimed at preventing the disease that has killed more than 1,400 people in the current outbreak in West Africa.

29 Aug 2014

University of Liverpool researchers identify pathogens that pose greater risk to people in Europe

The pathogens posing the greatest risk to Europe based upon a proxy for impact have been identified by University of Liverpool researchers using a 'big data' approach to scientific research.

28 Aug 2014

State highlights: Minn. vaccine requirements; Sovaldi in Calif. prisons; Ga. Rural ERs

For the first time in a decade, Minnesota schoolchildren are required to receive additional vaccines this fall. Seventh-graders now must get the meningococcal vaccination and an additional pertussis (whooping cough) booster.

27 Aug 2014

Viewpoints: Employers and health benefits; Sen. Pryor's ACA endorsement; waging war on hep C

Most of the political class seems to have decided that ObamaCare is working well enough, the opposition is fading, and the subsidies and regulation are settling in as the latest wing of the entitlement state.

25 Aug 2014

FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

ViiV Healthcare announced today that the US Food and Drug Administration has approved Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection.

23 Aug 2014

Longer looks: Falling teen birth rate; the right to pain relief; limiting access to Sovaldi

An infectious disease doctor at Tulane University, [MarkAlain] Dery treats people living with HIV in New Orleans and Baton Rouge, the two largest cities in the southern state of Louisiana, which itself has the fourth-highest rate of HIV in the United States, just behind New York, Florida and Maryland.

22 Aug 2014

State highlights: Audit says $93M in Medi-Cal payments could be fraudulent; Mass. insurers press on Medicaid pay

A selection of health policy stories from the District of Columbia, California, Massachusetts and Minnesota. The audit released Tuesday reviewed billing data from July 2008 to December 2013 for Medi-Cal's Drug Treatment program, which reimburses rehabilitation clinics.

21 Aug 2014

State highlights: Calif. hospital bid draws scrutiny; hospital house calls

Prime Healthcare Services Inc., a hospital chain that has come under fire for billing and patient privacy issues, is facing opposition over its potential acquisition of six California hospitals, including two medical centers in Los Angeles County. On Friday, hospital workers, union representatives and elected officials protested against Prime outside St. Vincent Medical Center near downtown Los Angeles, one of the six hospitals put up for sale this year by the Daughters of Charity Health System (Garland, 8/15).

19 Aug 2014

Mount Sinai researchers receive federal funding to treat HCV in primary care settings

With the number of people with chronic hepatitis C reaching record levels in New York City and the recent availability of more effective treatments, researchers from the Icahn School of Medicine at Mount Sinai recently announced the receipt of $1.9 million in federal funding to increase its capacity to treat HCV in primary care settings.

19 Aug 2014

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Immune Targeting Systems, specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (FlunisynTM) designed to protect humans from all strains of seasonal and pandemic influenza A.

18 Aug 2014

Hepatitis B News and Research

Latest Hepatitis B News and Research

Researchers examine whether new drug offers added benefit for patients with chronic HCV

State highlights: Texas lawmaker proposes '3 strikes' for nursing homes

Canada funds 22 inventive ideas for improving health in low-resource countries

New cancer drug renews debate about costs

Novira completes Phase 1a clinical study of NVR-1221 for treatment of HBV infection

First Edition: September 4, 2014

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Two fully automated molecular testing systems for blood and plasma donor screening launched by Roche

State highlights: States seek health care autonomy; L.A. nursing home audit; promoting overdose-reversal drug

High uptake of US infant vaccination in 2013

International consortium to accelerate collaborative multi-site trials of potential Ebola vaccine

University of Liverpool researchers identify pathogens that pose greater risk to people in Europe

State highlights: Minn. vaccine requirements; Sovaldi in Calif. prisons; Ga. Rural ERs

Viewpoints: Employers and health benefits; Sen. Pryor's ACA endorsement; waging war on hep C

FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

Longer looks: Falling teen birth rate; the right to pain relief; limiting access to Sovaldi

State highlights: Audit says $93M in Medi-Cal payments could be fraudulent; Mass. insurers press on Medicaid pay

State highlights: Calif. hospital bid draws scrutiny; hospital house calls

Mount Sinai researchers receive federal funding to treat HCV in primary care settings

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Industry Focus: Cell & Gene Therapy eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Hepatitis B News and Research

Latest Hepatitis B News and Research

Industry Focus: Cell & Gene Therapy eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in